-- アジェナス（AGEN）は火曜日、ボテンシリマブとバルスチリマブの併用療法に関するグローバルアクセスプログラムにおいて、BAPファーマを同社のグローバルパートナーに任命したと発表した。 これらのプログラムには、フランスの「人道的アクセス承認制度（Autorisation d'Acces Compassionnel）」に加え、米国以外の特定の国における有料の特定患者向けプログラムが含まれる。この契約に基づき、BAPファーマは、プログラム申請、物流、症例調整、関連する支払い処理など、グローバルアクセス業務全般を統括する。 この提携に関する財務条件は公表されていない。 アジェナスの株価は火曜日の取引で7.7%下落した。
Price: $4.08, Change: $-0.34, Percent Change: -7.69%
Investors in a Blue Owl Capital (OWL) business development company tendered less than 1% of shares to Boaz Weinstein's Saba Capital Management and Cox Capital Partners, which had offered to buy them out at a significant discount, Bloomberg reported Monday, citing people familiar with the matter.Blue Owl didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $8.97, Change: $-0.21, Percent Change: -2.29%
First Bancorp (FBP) shares were up 3.4% in Monday trading after Raymond James upgraded the company's stock to strong buy from outperform and raised its price target to $27 from $26.Trading volume stood at about 537,000 shares, compared with a daily average of around 1.5 million.Price: $24.23, Change: $+0.82, Percent Change: +3.48%
Advanced Micro Devices (AMD) shares were down over 3% in Monday trading after Northland downgraded the company's stock to market perform from outperform.Trading volume stood at more than 38.6 million shares, compared with a daily average of around 38.2 million.Price: $335.90, Change: $-11.91, Percent Change: -3.42%